EGFR kinase inhibitor 5
EGFR kinase inhibitor 5 (Compound 4c) is an orally active inhibitor for epidermal growth factor receptor (EGFR) kinase, with IC50 of 18.35 μM. EGFR kinase inhibitor 5 induces apoptosis. EGFR kinase inhibitor 5 exhibits anticancer and anti-inflammatory activity with low toxicity (LD50 range: 500-2000 mg/kg).
For research use only. We do not sell to patients.
- Formula: C21H16BrN3OS2
- Molecular Weight:470.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
IC50: 18.35 μM (EGFR Kinase)
EGFR kinase inhibitor 5 (0-80 μM, 72 h) inhibits migration of cancer cell A549, and exhibits anticancer activity against cancer cell A549, MCF7 and HCT116, with IC50s of 10.74, 18.73 and 23.22 μM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549
-
Concentration:0-30 μM
-
Incubation Time:24 h
-
Result:Inhibited cell migration.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Carrageenan-induced hind paw edema in Wistar rats model[1]
-
Dosage:0.0314 mmol/kg
-
Administration:p.o., 15 days
-
Result:Inhibited 80.17% paw edema.
Chemical Information
-
Molecular Weight 470.41
-
Formula C21H16BrN3OS2
-
SMILES
O=C1C(C)SC(C2=C(C3=CC=CC=C3)N=C4N2C=CS4)N1C5=CC=C(Br)C=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)